Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Delos Capitaldeloscapital.com · Low evidenceDelos Capital empowers life sciences leaders to transform bold ideas into medical breakthroughs by providing capital and strategic support. The firm invests in innovative biotech companies developing therapies for immune disorders, genetic medicines, and metabolic diseases.
Parse Score